Results 161 to 170 of about 13,071 (176)

Assessing the impact of fast-track drug registration by Anvisa in Brazil: A descriptive study of new drug registrations from 2017 to 2022

2023
exaly  

Validity and Scope of ANVISA’s Prior Consent to the Patentability of Medical Inventions

GRUR International, 2022
exaly  

Regulatory Approval for Oncology Products In Brazil: A Comparison Between The Fda And Anvisa Approval Timelines

Value in Health, 2015
F Roitberg, R Beckerman, S Duttagupta
exaly  

ANVISA APPROVES THE FIRST BIOSIMILAR MONOCLONAL ANTIBODY BASED ON COMPARABILITY IN BRAZIL

Arquivos De Gastroenterologia, 2016
Paulo Gustavo Kotze, Fabio Vieira Teixeira   +1 more
exaly  

Análise de Impacto Regulatório: uma nova ferramenta para a melhoria da regulação na Anvisa

Revista De Saude Publica, 2011
Alketa Peçi
exaly  

Pesquisas agronômicas das plantas medicinais da Mata Atlântica regulamentadas pela ANVISA

Revista Brasileira De Plantas Medicinais, 2012
Maria Izabela Ferreira, L C Ming, L C Ming   +2 more
exaly  

Should ANVISA be permitted to reject pharmaceutical patent applications in Brazil?

Expert Opinion on Therapeutic Patents, 2014
exaly  

Medical devices registration by ANVISA (Agência Nacional de Vigilância Sanitária)

Clinics, 2011
Richard Líébano, Bernardo Hochman
exaly  

The context and quality of evidence used by tobacco interests to oppose ANVISA’s 2012 regulations in Brazil

Global Public Health, 2018
Raphaël Lencucha
exaly  

Anvisa intensifica controle de infecção em serviços de saúde

Revista De Saude Publica, 2004
exaly